LUA-006

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameLUA-006
Drug Alias NameLUA-006LUA006LUA-006 (bispecific EGFR/B7-H3 ADC with dual payloads)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD276Anti-Epidermal growth factor receptor erbB1
TargetsCD276 antigenEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQilu Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A